NIH study showed higher mortality rates for patients on respiratory support in rural intermediate care units
On Jan. 31, 2024, a National Institutes of Health-supported study found that patients receiving ventilator life support in…
Pig kidney xenotransplantation performed optimally after 32 days in human body
On Aug. 16, 2023, surgeons at NYU Langone Health announed they had transplanted a genetically engineered pig kidney…
Vibativ effectively helped treat secondary bacterial infections in COVID-19 patients
On Jun. 21, 2021, Cumberland Pharma released a series of case reports describing the effectiveness of Vibativ (telavancin)…
Humanigen completed enrollment in phase 3 study of lenzilumab in hospitalized patients with COVID-19
On Jan. 29, 2021, Humanigen announced it had completed enrollment for its pivotal phase 3 study of lenzilumab…
COVID-19 pandemic sparked 3D printing engineering innovation
On Nov. 2, 2020, Pacific Northwest National Laboratory (PNNL) announced that in the Spring of 2020, as news…
NIH began large clinical trial to test immune modulators for treatment of COVID-19
On Oct. 16, 2020, the NIH launched an adaptive Phase 3 clinical trial to evaluate the safety and…
Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS
On Sept. 2, 2020, Mesoblast announced that it had received ethics approval to include Australian hospitals in the…
Philips EV300 ventilator supply contract with US Department of Health and Human Services to end
On Aug. 31, 2020, Royal Philips announced that it had received notice from the U.S. Department of Health…
WHO announced preliminary results about dexamethasone use in treating critically ill COVID-19 patients
On Jun. 16, 2020, the World Health Organization (WHO) announced that initial clinical trial results from the United…
The FDA approved antibiotic to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
On Jun. 4, 2020, the FDA approved Merck’s Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired…
Todos Medical announced cross-distribution agreement with L1 Systems for ventilators and COVID testing
On May 26, 2020, Todos Medical announced it had entered into a cross-distribution agreement with L1 Systems, a…
U of Alberta pharmaceutical institute leads effort to fill looming hospital drug shortage during fight against COVID-19
On May 11, 2020, a University of Alberta-initiated institute leads province wide effort to fill the looming shortage…
Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
ResMed accelerated release of ventilator telemonitoring platform to enable safer, more efficient patient care
On May 6, 2020, ResMed launched cloud-based remote monitoring software for ventilators and Lumis bilevel devices across Europe,…
FDA included ventilator developed by NASA in ventilator Emergency Use Authorization
On Apr. 30, 2020, the FDA included, under the ventilator emergency use authorization (EUA), a ventilator developed by…
Atossa Therapeutics contracted with NYC Health + Hospitals/Metropolitan for COVID-19 HOPE clinical study
On Apr. 27, 2020, Atossa Therapeutics announced that it had contracted with NYC Health + Hospitals/Metropolitan in New…
OHSU team designed low-cost ventilators using 3D-printing technology
On Apr. 24, 2020, Oregon Health & Science University (OHSU) announced that a research team led by Albert…
Mesoblast reported 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damage
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needs
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
Atossa Therapeutics launched COVID-19 HOPE drug development program
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
Ventilator Manufacturers Group established the Ventilator Training Alliance to help frontline medical workers during pandemic
On Apr. 15, 2020, Getinge announced support of the Ventilator Manufacturers Group to form Ventilator Training Alliance (VTA)…
FDA authorized first-of-its-kind low-cost ventilator developed by University of Minnesota
On Apr. 15, 2020, the U.S. Food and Drug Administration (FDA) authorized the production and use of a…
Philips detailed plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020
On Apr. 14, 2020, Royal Philips announced that it planed to double the production of its hospital ventilators…
Philips detailed plans to increase hospital ventilator production to 4,000 units/week by Q3 2020
On Apr. 14, 2020, Royal Philips updated its plans to double the production of its hospital ventilators by…
Philips joined forces with Flex and Jabil to speed the production of hospital ventilators
On Apr. 14, 2020, Philips announced that it had joined forces with manufacturing partners Flex and Jabil to…
New Philips Respironics E30 ventilator introduced to help free up ICU units in wake of COVID-19
On Apr. 14, 2020, Philips announced its initiative to quickly scale production of its new Philips Respironics E30…
Blood samples for Severely Ill COVID-19 patients indicate leronlimab has significantly reduced the Cytokine Storm in all patients
On Apr. 9, 2020, CytoDyn announced results of immunological metrics from blood samples of seven severely ill COVID-19…
Philips and US government collaborate in ventilator production ramp up to combat COVID-19 pandemic
On Apr. 8, 2020, Philips announced that the U.S. Government and Philips agreed to team up to increase…